118 related articles for article (PubMed ID: 6603557)
1. Cytotoxic responses induced by peptidoglycans with or without in vivo antitumor activity.
Goguel AF; Payelle B; Lespinats G; Nauciel C
J Natl Cancer Inst; 1983 Aug; 71(2):325-30. PubMed ID: 6603557
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of one particular subset of natural killer cells by peptidoglycans extracted from gram-positive bacteria.
Goguel AF; Payelle B; Quan PC; Lespinats G
J Natl Cancer Inst; 1984 Sep; 73(3):697-703. PubMed ID: 6590915
[TBL] [Abstract][Full Text] [Related]
3. Peptidoglycans extracted from gram-positive bacteria: expression of antitumor activity according to peptide structure and route of injection.
Goguel AF; Lespinats G; Nauciel C
J Natl Cancer Inst; 1982 Apr; 68(4):657-63. PubMed ID: 6803057
[TBL] [Abstract][Full Text] [Related]
4. Rat natural killer cell activity against lymphoid and nonlymphoid tumor cells and normal rat cell lines.
Rees RC; Reynolds CW; Herberman RB
Cancer Res; 1983 Sep; 43(9):4248-52. PubMed ID: 6871862
[TBL] [Abstract][Full Text] [Related]
5. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
[TBL] [Abstract][Full Text] [Related]
6. Different antitumor immunity roles of cytokine activated T lymphocytes from naive murine splenocytes and from dendritic cells-based vaccine primed splenocytes: implications for adoptive immunotherapy.
Zhang S; Wang Q; Li WF; Wang HY; Zhang HJ; Zhu JJ
Eksp Onkol; 2004 Mar; 26(1):55-62. PubMed ID: 15112581
[TBL] [Abstract][Full Text] [Related]
7. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
Li T; Harada M; Tamada K; Abe K; Nomoto K
Anticancer Res; 1997; 17(6D):4259-68. PubMed ID: 9494518
[TBL] [Abstract][Full Text] [Related]
8. [Coculture of dendritic cell with cytokine-induced killer results in a significant increase in cytotoxic activity of CIK to tumor cells in vitro and in vivo].
Ge W; Li CH; Zhang W; Han Q; Deng WM; Chen L; You SG; Zhao CH
Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):277-80. PubMed ID: 15182535
[TBL] [Abstract][Full Text] [Related]
9. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VII. Kinetic studies on various parameters of effects induced with suppressor cells.
Deutsch O; Devens B; Naor D
Isr J Med Sci; 1980 Jul; 16(7):530-7. PubMed ID: 6447122
[TBL] [Abstract][Full Text] [Related]
10. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
11. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the in vitro secondary cell-mediated cytotoxic response against syngeneic FBL-3 leukemia by macrophages.
Igarashi T; Teranishi T; Rodrigues D; Yamamura Y
Microbiol Immunol; 1980; 24(6):599-72. PubMed ID: 6968022
[TBL] [Abstract][Full Text] [Related]
13. Increased natural killer cell activity in experimental American trypanosomiasis.
Hatcher FM; Kuhn RE; Cerrone MC; Burton RC
J Immunol; 1981 Sep; 127(3):1126-30. PubMed ID: 6790614
[TBL] [Abstract][Full Text] [Related]
14. Study of adjuvant and mitogenic activities of bacterial peptidoglycans with different structures.
Guenounou M; Goguel AF; Nauciel C
Ann Immunol (Paris); 1982; 133D(1):3-13. PubMed ID: 6818895
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-12 (IL-12) gene therapy of leukemia: immune and anti-leukemic effects of IL-12-transduced hematopoietic progenitor cells.
Gautam SC; Xu YX; Dumaguin M; Janakiraman N; Chapman RA
Cancer Gene Ther; 2000 Jul; 7(7):1060-8. PubMed ID: 10917209
[TBL] [Abstract][Full Text] [Related]
16. In vivo induction of antitumor immunity and protection against tumor growth by injection of CD154-expressing tumor cells.
Grangeon C; Cormary C; Douin-Echinard V; Favre G; Couderc B; Tilkin-Mariamé AF
Cancer Gene Ther; 2002 Mar; 9(3):282-8. PubMed ID: 11896445
[TBL] [Abstract][Full Text] [Related]
17. Natural cytotoxic cells against solid tumors in mice: a comparison with natural killer cells.
Stutman O; Lattime EC; Figarella EF
Fed Proc; 1981 Oct; 40(12):2699-704. PubMed ID: 7286250
[TBL] [Abstract][Full Text] [Related]
18. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
19. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
Merritt RE; Yamada RE; Crystal RG; Korst RJ
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
[TBL] [Abstract][Full Text] [Related]
20. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. II. Separation of natural killer cells and cytotoxic T cells.
Le Gros GS; Herbert AG; Watson JD
Immunology; 1984 Jan; 51(1):103-13. PubMed ID: 6606615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
